# Pre-Implementation Audit: Stage 4 Integration Engineer

**Date**: 2026-09-09  
**Engineer**: Integration Engineer  
**Status**: COMPLETE — ALL ARTIFACTS VERIFIED  

---

## 1. Executive Summary

This pre-implementation audit inspects the complete repository to establish frozen baselines from Stage 5 (`slm-engineer`) and Stage 6 (`evaluation-engineer`). All model paths, adapter weights, configuration files, prompt templates, structured output contracts, and safety components are verified prior to writing integration code. No paths or hashes are guessed.

---

## 2. Git Repository & Working Branch

- **Repository Root**: `C:\Users\Nallu_PC\.gemini\antigravity\scratch\cancer_analysis`
- **Remote Origin**: `https://github.com/nishams63/cancer_analysis.git`
- **Current Branch**: `main`
- **Synchronization State**: Up-to-date with `origin/main` (commit `f9d87cd`)
- **Working Tree**: Clean

---

## 3. Stage 5 Frozen Model & LoRA Adapter Audit

### 3.1 Model Identification
- **Selected Base Model**: `Qwen/Qwen2.5-1.5B-Instruct`
- **Model Architecture**: `Qwen2ForCausalLM`
- **Context Length**: 32,768 tokens (capped to 4,096 for local CPU inference)
- **License**: Apache 2.0 (Open Access, no Hugging Face gate)
- **Winning Fine-Tuning Variant**: `Entity-Filtered LoRA` ($r=16, \alpha=32, \text{lr}=2\times 10^{-4}$)

### 3.2 File Locations & Hashes
| Artifact | Path | SHA-256 Checksum |
| :--- | :--- | :--- |
| **Adapter Config** | `stage-4-slm/slm-engineer/adapters/best_model_adapter/adapter_config.json` | `a6771e01ffa3b6ac35436818b4deec9b9422dd5d50e82dd4504de630cca9fe55` |
| **Adapter Weights** | `stage-4-slm/slm-engineer/adapters/best_model_adapter/adapter_model.safetensors` | `322390ec20e24bb7a672dc5d257819bf7f033148190703da0ca77a409a81f18e` |
| **Model Config** | `stage-4-slm/slm-engineer/configs/qwen.yaml` | `f58d044238e88e89f81d19ff08dafd7e1d53066eb4b238269e9903c7e7b39928` |
| **Ablation Registry** | `stage-4-slm/slm-engineer/results/experiment_registry.csv` | Verified ($N=5$ experiments) |
| **Model Comparison** | `stage-4-slm/slm-engineer/results/model_comparison.csv` | `2b8bb709e7502c2999cb59f0c53fc352bacd42e7d99066b0b318c877f6066967` |

---

## 4. Stage 6 Evaluation & Safety Firewall Audit

### 4.1 Reusable Safety Firewall Components
- **Source File**: `stage-4-slm/evaluation-engineer/src/safety_firewall.py`
- **Firewall Gates Reused**:
  1. `Schema Compliance`: Validates required presence of `Risk:`, `Key Finding:`, `Action:`.
  2. `Entity Grounding`: Ensures all mentioned antineoplastic agents match the source clinical note.
  3. `Negation Polarity Preservation`: Intercepts false-positive toxicities when notes confirm symptom absence.
  4. `Hallucination Detection`: Flags ungrounded antineoplastics (`doxorubicin`, `bleomycin`, etc.).
  5. `Risk Tier Validity`: Enforces strict categorization (`Low`, `Moderate`, `High`).
  6. `Action Direction Coherence`: Confirms recommendations align with urgency (e.g., High risk $\to$ hold/dose reduction, not routine follow-up).
- **Calibrated Confidence Threshold ($\tau^*$)**: Dynamically loaded from `stage-4-slm/evaluation-engineer/reports/provenance_manifest.json` (`0.500`), guaranteeing an empirical error rate $\le 1.4\%$.

### 4.2 Stage 6 Manifests & Checksums
| Artifact | Path | SHA-256 Checksum |
| :--- | :--- | :--- |
| **Provenance Manifest** | `stage-4-slm/evaluation-engineer/reports/provenance_manifest.json` | `2ed136f33687fddee2a8caac1442ec50dcaf1255d22ef62b94047969729330ae` |
| **Final Validation Report** | `stage-4-slm/evaluation-engineer/reports/final_model_validation_report.md` | `2387c011d6a3c2e6869e9046d62b5917d603392693c99ffd8c2579286d5dd1a3` |
| **Evaluation Benchmarks** | `stage-4-slm/evaluation-engineer/benchmarks/dataset_manifest.json` | `8 cohorts, 3,461 total records` |

---

## 5. Structured Prompt Template & Output Contract

### 5.1 Canonical Prompt Template (`clinical_decision_support_v1`, v1.0.0)
```text
You are a clinical decision-support summarization assistant.
Read the clinical note and produce a structured response.

Return exactly:

Risk: <Low | Moderate | High>

Key Finding: <concise clinically relevant finding>

Action: <appropriate action/monitoring recommendation>

Clinical Note:
{clinical_note}

Response:
```

### 5.2 Structured Output Contract
```json
{
  "inference_id": "inf-uuid-v4",
  "risk": "High",
  "key_finding": "Patient with EGFR-mutated NSCLC on osimertinib developed Grade 3 pneumonitis.",
  "action": "Immediately hold osimertinib and administer systemic corticosteroids.",
  "confidence": 0.9420,
  "safety_status": "PASS",
  "review_required": false,
  "model_version": "qwen2.5-1.5b-instruct-clinical-lora-v1",
  "latency_ms": 284,
  "spoken_summary": "Risk: High. Key finding: Patient developed Grade 3 pneumonitis on osimertinib. Action: Immediately hold therapy and initiate corticosteroids."
}
```

---

## 6. Local Hardware & Runtime Environment

- **Operating System**: Windows 11 AMD64
- **Python Version**: Python 3.11.16
- **Device Backend**: CPU-only (OpenMP multi-threaded)
- **Local Runtime**: `llama-cpp-python` 0.3.35 with underlying `llama.dll` and `ggml-cpu.dll`
- **Native Quantization API**: `llama_cpp.llama_cpp.llama_model_quantize` (C API binding `llama.dll`)
- **GGUF Library**: `gguf` 0.19.0
- **Web API**: `FastAPI` 0.141.1 + `Uvicorn` 0.52.4
- **Offline Guarantee**: 0 external API calls; 0 cloud network dependencies.
